The growing world of CAR T cell trials: a systematic review Astrid HolzingerMarkus BardenHinrich Abken Review 09 September 2016 Pages: 1433 - 1450
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer Mariëtte I. E. van PoelgeestValeria V. ViscontiMarij J. P. Welters Original Article Open access 12 September 2016 Pages: 1451 - 1463
Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma Sarah Maria JohlerJörg FuchsSorin Armeanu-Ebinger Original Article 15 September 2016 Pages: 1465 - 1476
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells Toshiko KamataAkane SuzukiShinichiro Motohashi Original Article Open access 15 September 2016 Pages: 1477 - 1489
Anti-PD-1 inhibits Foxp3+ Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model Lydia DyckMieszko M. WilkKingston H. G. Mills Original Article 28 September 2016 Pages: 1491 - 1498
Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma Yasuharu AkasakiTetsuro KikuchiYuichi Murayama Original Article 29 September 2016 Pages: 1499 - 1509
Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models Emily A. LanzelM. Paula Gomez HernandezKim A. Brogden Original Article 29 September 2016 Pages: 1511 - 1522
Killer immunoglobulin-like receptor (KIR) and KIR–ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2 Wei WangAmy K. ErbePaul M. Sondel Original Article 30 September 2016 Pages: 1523 - 1532
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma Ajjai AlvaGregory A. DanielsJanice P. Dutcher Original Article Open access 06 October 2016 Pages: 1533 - 1544
Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models Anning LiYue WuJohn W. Chen Original Article 08 October 2016 Pages: 1545 - 1554
Anti-GITR therapy promotes immunity against malignant glioma in a murine model Jason MiskaAida RashidiMaciej S. Lesniak Original Article 12 October 2016 Pages: 1555 - 1567